Monthly revenue and year-on-year change for PEC (6446) and WeLeader Biomedical (7713) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | PEC | YoY | WeLeader Biomedical | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$2.84 billion | +102.0% | NT$112.6 million | +15.3% |
| Sep 2026 | NT$2.64 billion | +100.0% | NT$116.6 million | +16.8% |
| Aug 2026 | NT$2.62 billion | +105.4% | NT$116.2 million | +14.8% |
| Jul 2026 | NT$2.51 billion | +92.6% | NT$120 million | +26.4% |
| Jun 2026 | NT$2.33 billion | +94.9% | NT$112.9 million | +15.2% |
| May 2026 | NT$2.46 billion | +108.5% | NT$111.3 million | +20.6% |
| Apr 2026 | NT$2.06 billion | +68.3% | NT$115 million | +38.8% |
| Mar 2026 | NT$1.94 billion | +64.4% | NT$102.3 million | +14.3% |
| Feb 2026 | NT$1.6 billion | +56.7% | NT$78.3 million | +4.6% |
| Jan 2026 | NT$1.58 billion | +49.8% | NT$98.3 million | +21.7% |
| Dec 2025 | NT$1.92 billion | +69.9% | NT$96.6 million | +21.0% |
| Nov 2025 | NT$1.55 billion | +53.0% | NT$100.9 million | +14.7% |
| Oct 2025 | NT$1.4 billion | +53.6% | NT$97.7 million | +22.0% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16